Monashee Investment Management LLC Takes Position in Shoulder Innovations, Inc. $SI

Monashee Investment Management LLC bought a new position in shares of Shoulder Innovations, Inc. (NYSE:SIFree Report) during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 40,000 shares of the company’s stock, valued at approximately $502,000. Monashee Investment Management LLC owned 0.20% of Shoulder Innovations as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also recently modified their holdings of SI. Rhumbline Advisers purchased a new position in shares of Shoulder Innovations during the third quarter valued at $54,000. Board of Trustees of The Leland Stanford Junior University purchased a new position in Shoulder Innovations during the 3rd quarter valued at about $170,000. Readystate Asset Management LP purchased a new position in Shoulder Innovations during the 3rd quarter valued at about $511,000. Vanguard Group Inc. bought a new position in shares of Shoulder Innovations during the third quarter valued at approximately $1,836,000. Finally, Federated Hermes Inc. purchased a new stake in shares of Shoulder Innovations during the 3rd quarter worth $2,510,000.

Insider Buying and Selling

In other news, CEO Robert Joseph Ball bought 3,900 shares of the business’s stock in a transaction dated Friday, December 12th. The stock was purchased at an average cost of $14.89 per share, with a total value of $58,071.00. Following the acquisition, the chief executive officer directly owned 118,457 shares in the company, valued at $1,763,824.73. This trade represents a 3.40% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders bought 9,200 shares of company stock worth $136,642 over the last quarter. 1.71% of the stock is owned by company insiders.

Shoulder Innovations Stock Up 1.2%

Shoulder Innovations stock opened at $13.63 on Friday. The business’s 50-day simple moving average is $14.01 and its two-hundred day simple moving average is $13.85. The company has a debt-to-equity ratio of 0.10, a quick ratio of 9.80 and a current ratio of 11.09. The company has a market cap of $280.68 million and a PE ratio of -0.12. Shoulder Innovations, Inc. has a fifty-two week low of $10.92 and a fifty-two week high of $17.94.

Analyst Ratings Changes

Several research analysts recently commented on SI shares. Morgan Stanley boosted their price objective on shares of Shoulder Innovations from $18.00 to $23.00 and gave the stock an “overweight” rating in a research note on Tuesday, December 2nd. Weiss Ratings reaffirmed a “sell (e)” rating on shares of Shoulder Innovations in a report on Monday, December 29th. Piper Sandler reiterated an “overweight” rating and set a $18.00 price objective on shares of Shoulder Innovations in a report on Wednesday, November 12th. Finally, The Goldman Sachs Group reissued a “buy” rating on shares of Shoulder Innovations in a research report on Friday, January 9th. Five investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, Shoulder Innovations presently has a consensus rating of “Moderate Buy” and a consensus target price of $20.60.

Read Our Latest Analysis on Shoulder Innovations

Shoulder Innovations Company Profile

(Free Report)

Shoulder Innovations (NYSE:SI) is a medical device company focused on the design, development and commercialization of shoulder implant systems and related surgical instruments for orthopedic surgery. The company’s product portfolio includes modular shoulder prostheses, humeral and glenoid components, and instrumentation kits designed to facilitate both primary and revision shoulder arthroplasty procedures. Emphasizing a patient-centric approach, Shoulder Innovations works to offer implant solutions that aim to restore mobility and reduce post-operative complications.

In addition to its core implant offerings, Shoulder Innovations provides comprehensive clinical support and training programs for surgeons and operating room teams.

Further Reading

Want to see what other hedge funds are holding SI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Shoulder Innovations, Inc. (NYSE:SIFree Report).

Institutional Ownership by Quarter for Shoulder Innovations (NYSE:SI)

Receive News & Ratings for Shoulder Innovations Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shoulder Innovations and related companies with MarketBeat.com's FREE daily email newsletter.